Such results indicate that CD4+CD25+ Tregs from MG patients are unable to effectively suppress the proliferation of their CD4+CD25− T cells, so the suppressive function of CD4+CD25+ Tregs from MG patients is impaired. This evidence concerns the gene CD4 and myasthenia gravis.